Ligand validation:2WYN

GLC: alpha-D-glucopyranose

GLC is a Ligand Of Interest in 2WYN designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2WYN_GLC_C_1548	98%	56%	0.059	0.979	0.65	1.02	-	1	0	0	100%	1
2WYN_GLC_D_1548	97%	63%	0.063	0.98	0.58	0.84	-	-	0	0	100%	1
2WYN_GLC_A_1548	96%	65%	0.075	0.987	0.47	0.87	-	-	1	0	100%	1
2WYN_GLC_B_1548	91%	57%	0.093	0.981	0.66	1	-	-	0	0	100%	1
2JJB_GLC_D_1548	98%	55%	0.07	0.989	0.73	1	-	2	0	0	100%	1
5O59_GLC_A_608	100%	61%	0.025	0.992	0.81	0.69	-	-	0	0	92%	0.9167
8R4G_GLC_C_1001	100%	39%	0.042	0.991	0.8	1.57	1	3	1	0	100%	1
3W7S_GLC_A_1002	99%	64%	0.046	0.974	0.56	0.83	-	-	0	0	100%	1
5MTT_GLC_A_407	98%	66%	0.053	0.993	0.38	0.92	-	-	0	0	92%	0.5867

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.